Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the durability of effect of Droxidopa in treating
symptoms of neurogenic orthostatic hypotension in patients with Primary Autonomic Failure
(Pure Autonomic Failure, Multiple System Atrophy, Parkinson's Disease), Non-diabetic
neuropathy, or Beta Hydroxylase deficiency.